Health and Medicine
Mar. 4, 2021—Evotec, a drug company headquartered in Hamburg, Germany, has begun a phase 1 clinical trial of a monoclonal antibody against the chikungunya virus that was identified at Vanderbilt University Medical Center.
Mar. 2, 2021—VUSN Professor Dr. April Kapu, DNP, APRN, ACNP-BC, FAANP, FAAN, was recently interviewed by the Clinical Advisor per the controversy over USDA-HHS Dietary Guidelines. Dr. Kapu commented: “Obesity and detrimental effects of alcohol have tremendous negative consequences on health. I would encourage the USDA-HHS to continue study into the effects of sugar and alcohol consumption and evidence-based...
Vanderbilt-developed obesity treatments will be advanced through collaboration with Soleno Therapeutics
Feb. 25, 2021—A new partnership between Vanderbilt University’s Warren Center for Neuroscience Drug Discovery and clinical stage biopharmaceutical company Soleno Therapeutics will further research into new clinical treatments for multiple obesity syndromes.
Feb. 23, 2021—In Tampa, Florida, in the early 1980s, young men were coming home to their parents to die. As a registered nurse, Julie Barroso cared for many of these AIDS patients in their final days.
Feb. 17, 2021—Vanderbilt biochemist Yi Ren is part of a team that has identified a new behavior of a SARS-CoV-2 protein and discovered that interfering with its function can block virus replication in host cells. This opens up the potential for new therapeutic targets for COVID-19.
Feb. 16, 2021—Assistant Professor of Chemistry Steven D. Townsend, PhD’10, has been awarded a 2021 Sloan Research Fellowship, one of the highest honors for young scientists who have the potential to revolutionize their fields of study.
Feb. 15, 2021—Vanderbilt first-year students recently met with Buddy Creech, director of the Vanderbilt Vaccine Research Program and associate professor of pediatrics, for a special virtual chat to answer some of their COVID-19 vaccine questions.
Feb. 12, 2021—Bruce Carter, professor of biochemistry and an associate director of the Vanderbilt Brain Institute, has been appointed to the scientific advisory board of the CMT Research Foundation, which shapes research directions and therapeutic development of Charcot-Marie-Tooth disease.
Feb. 9, 2021—Biomedical researchers across Vanderbilt University will convene to discuss the history and impact of Black biomedical scientists on Monday, Feb. 15, at noon CT.
Feb. 4, 2021—A new method speeds the analysis of factors that control gene expression from days to minutes, allowing researchers to uncover new targets for cancer treatment.
Trans-institutional collaboration receives $2 million BRAIN Initiative grant, developing brain organoids to map neurological development
Feb. 1, 2021—Researchers will combine expertise in developmental cell biology and tissue engineering/microfluidics to develop highly complex organoids, with the goal of understanding currently incurable neurological disorders.
Vanderbilt joins Wellcome Leap global network dedicated to accelerating breakthroughs in human health
Jan. 28, 2021—Vanderbilt University has joined the Leap Health Breakthrough Network, a global group of leading academic and research institutions committed to solving the world’s most serious health challenges.